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The aim of this study was to compare the effects of arginine vasotocin (AVT)
administration in the endangered boreal toad (Bufo boreas boreas) and common Fowler’s
toad (Bufo fowleri). The objectives of this study were to determine if AVT could elicit: 1)
calling, and 2) amplexus behaviors. Toads were paired into single male:female groups
and administered AVT at varying concentrations: 0.1, 1.0, 5.0, 10.0 and 25.0 µg/g and in
different combinations: 1) only male was treated; 2) only female was treated, and 3) both
male and female treated. AVT failed to stimulate any breeding behavior in the boreal
toad, but the administration of AVT to both B. Fowleri genders significantly affected the
duration of amplexus (p<0.0347). Also, the concentration of AVT significantly affected
the length of amplexus (p<0.0429) and call frequency (p<0.0294). These results will be
valuable for breeding programs where animals are failing to show natural reproductive
behavior.
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CHAPTER I
INTRODUCTION

Wild amphibian populations are experiencing global biodiversity crises which are
threatening the existence of many species. It has been estimated that 168 species have
already gone extinct within the last few decades and 43% of the remaining populations
are in a state of decline (1). There are many factors driving the decline of amphibian
populations, of which habitat destruction is the major force. Other factors include
pollution, pathogens, ultraviolet radiation, exotic animal introduction, human harvesting
and global climate change (2, 3). One of the study species in this thesis study is the
boreal toad, Bufo boreas boreas, an endangered species from the Southern Rocky
Mountain region. Like many amphibians, it was once common but has recently
encountered a serious decline (39).
One of the greatest challenges facing amphibian survival is the spread of
Batrachochytrium dendrobatidis, also known as chytrid fungi. This group of fungi are
very diverse and have been found in a multitude of environments such as deserts,
rainforests and the arctic tundra (4). Chytrid is a very deadly fungus that has decimated
entire populations within the short period of a few months (5). Species that are
particularly vulnerable to chytrid, such as the boreal toad, dwell in high altitude regions
with restricted ranges. The spores of the fungi disseminate in water and can rapidly
1

migrate through lakes and streams. A natural biodegrader of chitin, the fungus attacks
the chitin present within the amphibian’s superficial keratinized skin layer (5). The
fungal infection can then spread to other internal organs and cause death. This has been
the main contributing factor to the decline of the boreal toad species.
Captive breeding programs have been established to help combat the drastic
amphibian declines. The main purpose of these programs is to assist in the reproduction
of endangered species for wild repopulation. One of the toughest challenges faced is the
ability to implement a successful breeding regiment. These regiments usually consist of
the application of assisted technologies such as administration of exogenous hormones
and artificial fertilization. Unfortunately, very little is known about the mechanisms of
reproduction in many amphibian species and these gaps in knowledge make it difficult to
successfully induce breeding.
When amphibians diverged onto land millions of years ago, they evolved a wide
variety of reproductive modes. It is the heterogeneous nature of the reproductive
strategies that makes amphibians so exciting to study, but which also presents a greater
challenge for research. Even within the same genus, scientists cannot necessarily
implement the same breeding regiment across multiple species (6). Before proceeding
with a hormone regiment, it is important to first establish a species specific, physiological
response.
The aim of this thesis project was to determine the effects of the hormone arginine
vasotocin (AVT) on amphibian reproduction. The effects of this hormone have been
studied extensively in other amphibian species, but have not yet been explored in the
boreal toad. The effects of AVT were also compared to another species, the fowler’s
2

toad (Bufo fowleri). The Fowler’s toad is a common species located in the eastern United
States (40).

This comparative study will help provide greater understanding of the

hormone’s effects on reproduction in two species of the bufonidae family. The goal of
this study was to examine if AVT can be used in a breeding regiment that is capable of
improving endangered amphibian reproduction as well as help further the understanding
of basic amphibian physiology. To the best authors’ knowledge, there are no studies
which have reported induced amplexus after AVT administration in any anuran species.
One aim of this investigation was to see if AVT can induce this behavior in either of the
two species. Although the effects of AVT administration on amphibian male
reproduction have been studied extensively in previous research, very little focus has
been placed on female amphibians and even less on the effects of stimulating both male
and female simultaneously. This study was able to examine the effects of AVT
administration on reproductive stimulation both singularly in the male and female toad
and during mate pairing.
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CHAPTER 2
LITERATURE REVIEW

Arginine Vasotocin
Arginine vasotocin (AVT) is the ancestor hormone to the mammalian analogue,
arginine vasopressin (AVP 7, 8). It is a member of the neurohypophyseal peptide family.
This family dates back to early vertebrate evolution and includes the hormones oxytocin
and mesotocin. AVT is present in fish, reptiles, birds and amphibians. The neuropeptide
evolved into AVP through the loss of the isoleucine peptide in its residue chain. Because
of the similarity in structure between species, the knowledge gained of AVT in
amphibians can help improve understanding of AVP in mammals (7, 8).
As discussed in this literature review, AVT cell bodies are located within the
magnocellular and parvocellular neurons in the preoptic area-anterior hypothalamus (8,
9). The fibers extend into the hypophysis and spinal cord to then travel through the rest
of the nervous system. The distribution of AVT receptors varies greatly depending on
species and sex (7, 8). The effects of AVT are dependent upon the concentration and
distribution of these receptors, which in turn, are effected by gonadal steroids (10).

4

The Effects of Arginine Vasotocin on Sensorimeter Processing
One of the main effects of AVT is the induction of reproductive behaviors (8, 9).
It can induce calling, phonotaxis and amplexus in certain amphibian species and can also
induce spermiation and egg deposition. AVT works in concert with androgens to mediate
behavioral responses to sensory signals. Typically, males rely on visual cues first to
locate gravid females. After locating a possible gravid female, males then use
pheromonal cues to determine if she has been mated. The last main sensory effect of
AVT is the enhanced clasping response of a male during amplexus in response to tactile
stimulation.

The Effects of Arginine Vasotocin on Visual Stimuli
The first sensory cue employed by males during breeding is visual stimuli. Visual
cues are used to locate possible female mates. Rose and Moore (2002) studied the effects
of AVT when administered to rough skinned newts, Taricha granulosa (8). Males
injected with AVT were more attracted to clear beakers containing females as compared
to males only injected with saline. However, this response was found to be
nondiscriminatory. The AVT-injected males were also attracted to beakers containing
other male newts, earthworms and even a moving finger. The authors hypothesized that
AVT enhanced the neuronal signals produced from the visual centers in the male brain
which in turn stimulated their response to nonspecific moving stimuli.
Another surprising result from the previous study was the reduction of neuronal
response to light. Since AVT was found to increase visual response to movement, it was
expected to also have a facilitative effect on the optic tectum. This center of the brain is
5

responsible for controlling the amphibian’s fear response to light as an adaptive
mechanism. As prey species, amphibians are typically photophobic and will hide in dark
waters or under shelter. Doing so enables amphibians to avoid predation. In contrast,
Rose and Moore found individuals had an decreased fear response after AVT
administration and observed reduced neuronal responses when the subjects were
subjected to flashes of light (8). This unexpected response could be the result of an
adaptive modification during the breeding season. During this time amphibians must
sacrifice personal safety in order to seek mates. Specifically in the rough skinned newt,
males will reside in the shallow waters along the edges of breeding ponds to intercept
incoming females. Consequently, the effect of AVT will decrease their photophobic
response to light so that they are incited to remain exposed in the shallow waters and
await incoming females.

The Effects of Arginine Vasotocin on Olfactory Stimuli
After males visually locate potential females, they will assess their reproductive
status using olfactory cues. The production of certain pheromones is dependent on
whether a female has been mated or not. In the case of the rough skinned newt, males
were attracted to foam pads scented with the pheromones of unmated females (8). The
males also exhibited an amplectic response when exposed to plastic models of female
newts that were marked with female pheromones. Males administered with AVT spent
more time in close proximity to the pheromone scented models as compared to males
injected with only saline (11). Males administered with AVT were also more attracted to
the foam pads marked with female pheromones as compared to saline injected males.
6

This finding suggests that the males were particularly attracted to the pheromones
produced by females and not simply to the female shape. Compared to previous visual
studies which found that AVT injected males displayed a nondiscriminatory response to
moving objects, pheromone studies indicated that the olfactory cues employed by male
newts were specific to female sexual pheromones.

The Effects of Arginine Vasotocin on Tactile Stimuli, Amplexus
One of the key functions of arginine vasotocin is its ability to stimulate an
amplectic response in the male amphibian (12). Amplexus behavior has been defined as
a male amphibian clasping a female during natural mating. The male positions himself
dorsally over the female’s back, and clasps her with his forelimbs, hind limbs, or both.
Pressure and movement of the female on the male’s ventrum serves as cloacal
stimulation. This can help strengthen and maintain the amplectic response.
In the study conducted using male rough skinned newts, AVT administration
increased neuronal response to cloacal stimulation (12). Unexpectedly, AVT
administration also increased neuronal response when stimuli were applied to other
locations such as limbs. However, the magnitudes of these responses were not as great.
AVT has induced an amplectic effect in many amphibian species (8, 13, 14),
though the exact responses have not been the same across species. The concentrations
needed to induce an amplectic response varied drastically between studies. In a study
conducted using the great plains toad Bufo cognatus, 0.001, 0.1 and 1.0 µg/g of AVT
were administered and did not stimulate any amplectic response (15). Other studies have
found a profound effect at very little doses, such as 0.1µg when administered to male
7

rough skinned newts (13). It has been suggested that the effects of AVT on the induction
of amplexus can be dependent on the number of vasotocin receptors located within
different brain regions. As discussed later, this can be species and gender-specific. The
number of receptors may also vary between seasons (13).

Arginine Vasotocin Interaction with Corticosterone on Amplexus
A surprising finding from previous AVT studies is its interaction with the
hormone, corticosterone. Corticosterone is a glucocorticoid produced within the adrenal
cortex and secreted in response to stress. Previous research indicates that high levels of
corticosterone production can inhibit reproduction (8). Recently however, it now appears
that corticosterone may interact with arginine vasotocin in a positive manner under
certain circumstances (12). When male rough skinned newts were administered
corticosterone 30 minutes prior to AVT, their reproductive neuronal response were
repressed as expected. However, when AVT was administered prior to corticosterone by
10-17 minutes, the males exhibited a pronounced increase neuronal response to
reproductive stimuli (cloacal stimulation). This finding suggested that the varying
responses could be the result of adaptive behavior during natural mating. For example, if
a male newt has amplexed a female, he will be expected to have increased levels of AVT
influencing this behavior. In the wild, this amplexed male may be challenged by another
male to compete for the gravid female. This interaction may induce a stress response in
the amplexed male, resulting in the secretion of corticosterone. Cooperatively,
corticosterone and AVT will stimulate the male to trigger stronger clasps so that he will
not be removed by his challenger.
8

Another adaptive mechanism for corticosterone and AVT interaction is when an
amphibian needs to seek shelter instead of a mate (8). As discussed earlier, AVT can
decrease an amphibian’s photophobic response to light. This influences the amphibian to
come out of a safe, dark shelter and pursue a potential mate in shallow, well-lit waters.
While helpful for reproducing, it makes the animal more vulnerable to predation. With
this in mind, the authors suggested that this could explain why a decreased reproductive
neuronal response to cloacal stimuli when a male newt was administered corticosterone
30 minutes prior to AVT.

The Effects of Arginine Vasotocin on Male Calling
One of the most studied effects of AVT on amphibian behavior is its ability to
stimulate calling in males. AVT has been found to induce calling in many species
including green tree frogs (Hyla cinera(16, 17), Great Plains toads (Bufo cognatus (15),
bullfrogs (Rana catesbeiana) and cricket frogs (Acris crepitans (18). Males use calling
as a form of communication, which can be used for attracting potential female mates or
as a territorial behavior against competing males. Males will often exhibit territoriality in
order to establish a fixed site that can supply limited resources. This can often increase
the male’s attractiveness to potential female mates (19). It can also increase a male’s
direct access to females located in the same area.
In the cricket frog, males use different acoustics depending on whether they are
attempting to attract a female or have encountered a conspecific male (18). Amphibians
produce calls which are composed of variable pulses and spectral characteristics (20).
The characteristics of calls can vary depending on the social circumstance. After
9

administration of AVT, some amphibian species have shown a change in call
characteristics such that the calls were less aggressive and more similar to advertisement
calling. For example in the cricket frog, AVT administration influenced more nonaggressive calling. While speculative, the authors felt it was possible that the males
produced more non-aggressive calling because these calls may have been considered
more attractive to females (18).
The Puerto Rican Crested toad (Peltophryne lemur) is another species that
exhibits male advertisement calling. The males of this species exhibit a complex social
hierarchy. It consists of males defined as territorial (calling), satellite (submissive, noncalling) and parental (males which guard and brood embyros 19). After AVT
administration, a significant number of the satellite males moved to new areas, outside of
the territorial males’ ranges. They then proceeded to produce advertisement calling.
They also exhibited territorial behavior and assumed a dominant posture. These males
were then approached by prospective females. The authors hypothesized that the
administration of AVT increased their reproductive arousal and thus encouraged them to
seek new territory and female mates.

The Effects of Arginine Vasotocin on Male Spermiation
It has been hypothesized that the administration of AVT can induce spermiation
in amphibian males. A study conducted by Zoeller et al. (1983) observed a contractile
effect of the male rough skinned newt’s Wolffian ducts following AVT administration.
Another study also observed a spermiation effect in the Japanese Fire-Bellied newt
Cynops pyrrhogaster (21).
10

While the previously mentioned studies showed positive results, another study
conducted by Silla (2010) observed an inhibitory effect of AVT on spermiation in the
Günther’s toadlet, Pseudophryne guntheri. First, the optimal dose of Lutenizing
Hormone Releasing Hormone (LHRH) required to stimulate spermiation was determined.
Then AVT was administered in combination with the optimal LHRH dose and also by
itself. Both the administration of AVT alone and in combination with LHRH resulted in
decreased sperm production as compared to administration of just LHRH. The author
hypothesized that AVT did not elicit a successful spermiation response when
administered alone, and that it had a negative effect on the spermiating response to
LHRH. For future studies, the author suggested that administering AVT in combination
with human chorionic gonadotropin (hCG) may result in improved spermiation. The
basis for this hypothesis stemmed from a study conducted by Yamashita et al. in 1980
that observed a suppression of Lutenizing Hormone (LH) release and gonadal function
following AVT administration in the dog (22). Decreased gonadal function was also
observed in the dog following the combined administration of AVT and LHRH.
However, gonadal function remained intact when AVT was administered in combination
with hCG. Yamashita et al. hypothesized that the improved gonadal function was a result
of hCG acting directly on the gonads, bypassing AVT’s inhibition of the hypothalamus
and pituitary in the brain (22).

The Effects of Arginine Vasotocin on Female Amphibians
While not studied as extensively as in males, AVT is able to stimulate
reproductive effects in some female amphibian species. The effects most often observed
11

are the stimulation of phonotaxis, egg deposition, male behavior and inhibition of release
calling.

The Effects of Arginine Vasotocin on Female Phonotaxis
Sexually mature female amphibians will locate potential male mates by their
advertisement calling. Previous research has found that this behavior, titled phonotaxis,
is modulated by prostaglandin in the American toad (Bufo americanus (23, 24). It can
also be induced through the combined intracerebroventricular administration of
progesterone and AVT (25). Female toads significantly increased the display of
phonotaxis after receiving a hormone regimen using progesterone as a priming hormone
and AVT as the final stimulatory hormone.
Previous studies using the bullfrog have also seen increased phonotaxis response
after AVT administration (26). After AVT was administered to females intraperitoneally,
the time required to reach the male call source decreased significantly. Their response
was quick, starting at half an hour after administration and remained significant for up to
two hours.

The Effects of Arginine Vasotocin on Inhibiting Female Release Calling and Egg
Deposition
Females and males both exhibit release calls when inappropriately clasped. It is
exhibited in males when clasped by other males and exhibited in females when clasped
during a time that they do not want to breed (27). The administration of AVT will
decrease release calling in certain female amphibians, such as the bullfrog (7). This
12

decreased release calling typically indicates that the female is more receptive to be
amplexed by the male and deposit eggs for fertilization.
Stimulating female egg deposition is one of the most advantageous applications of
AVT in captive breeding programs. One of the difficulties faced in simulating egg
deposition is that many species naturally undergo a state of hibernation before final
oocyte maturation can occur (6). Often, breeding programs are unable to replicate the
conditions needed to properly induce hibernation. Even after hibernation, many females
may still fail to successfully deposit eggs and can encounter problems with dystocia.
Because of this, many programs aim to overcome the need to hibernate through the use of
exogenous hormones, such as arginine vasotocin.
The induction of egg-laying behavior has been observed after AVT administration
in certain amphibian species such as the rough skinned newt (28). When intact females
were injected with AVT, they exhibited increased clasping behavior. Furthermore, AVTinjected ovariectomized females that were implanted with estradiol, testosterone and
dihydrotestosterone (DHT) all exhibited natural egg-laying behavior by clasping onto
aquatic vegetation. Females implanted with saline alone exhibited no clasping behavior.
This illustrated that clasping effects of AVT are maintained through these sex steroids.
The authors of this study were interested in AVT’s effects on female egg-laying
behavior because of its similarity to male amplexus behavior. Further investigations
found that ovariectomized females implanted with DHT and injected with AVT
preferentially clasped onto other females, a male-like behavior (28). This particular
effect of AVT will be discussed in more detail later. Females implanted with estradiol
showed no preference to clasping onto other females. The authors concluded that it was
13

likely that the combined effect of estradiol and AVT stimulated natural egg-laying
behavior in the female amphibian.
Increased follicle development following AVT administration has also been
observed in other species such as the catfish (Heteropneustes fossilis; (29). Postvitellogenic follicles were collected then incubated with AVT. Germinal vesicle
breakdown and ovulation was recorded as a measure of final oocyte maturation and were
found to significantly increase after AVT incubation. After AVT incubation, oocyte
hydration also significantly increased through measurements of follicular diameter,
volume, water content, water osmolality and calcium concentration (30). These studies
indicated a positive effect of AVT on follicle development and ovulation.

The Effects of Arginine Vasotocin on Female Male-Like Behavior
Females can naturally exhibit clasping behavior similar to male amplexus when
clasping on to aquatic vegetation during egg deposition. One of the more surprising
effects of AVT is its ability to stimulate male-like behaviors in female amphibians.
Ovariectomy of rough skinned female newts can increase female-female clasping after
DHT implantation and AVT injection (28).
Ovariectomized females were implanted with either estradiol or
dihydrotestosterone (DHT). When offered both aquatic vegetation and other female
newts, the AVT-injected females with DHT-implants showed an increased preference
toward clasping other females. Although it is virtually impossible to say for certain that
the female-female clasping was a result of exhibiting male courtship behavior and not
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egg-laying behavior, it is likely that the increase in androgen supplementation altered
their response to prefer conspecific female stimuli (28).

Interactions of Arginine Vasotocin and Other Endogenous Reproductive Hormones
One of the key aspects of AVT is its interactive effects with other endogenous
reproductive hormones. AVT is influenced by sex steroids in both male and female
amphibians. This effect is evidenced by the sexual dimorphism of AVT peptide cell
bodies within the amphibian brain (31).
A study conducted using the rough skinned newt examined the locations and
numbers of vasotocin cell bodies within both male and female brains across seasons (31).
The results indicated that some populations of the vasotocin cell bodies were sexually
dimorphic and/or changed during different seasons. Of particular interest was the
observation of increased vasotocin cell bodies located within the male anterior preoptic
area (aPOA). This brain area has been linked to male sexual behaviors in many
vertebrates, including the amphibian (32, 33). Other sexual dimorphisms observed were
increased number of vasotocin cell bodies located in the bed nucleus of the stria
terminalis (BNST) and the nucleus amygdalae dorsolateralis (AMYG) in male rough
skinned newts. These brains areas have also been linked to male sexual behaviors.
Increased numbers of vasotocin cell bodies have been located in female brains
across the pars dorsalis hypothalamic and ventromedial hypothalamus (9, 34). These
areas have been associated with female sexual behavior in the amphibian. However, in
the study conducted by Moore et al. (2000), the numbers of vasotocin cell bodies did not
significantly increase during breeding months of February and August (31). This finding
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was surprising because those are the months when mating behavior is naturally exhibited
in the female rough skinned newt. Instead, there was significantly increased numbers of
cell bodies present in April, during the time in which egg-laying occurs. The authors
suggested that this increase of vasotocin could be an adaptive female response to aid in
exhibiting egg-laying behavior.
The study indicated that aside from the previously mentioned change in female
AVT cell bodies during egg-laying, there was no significantly clear relationship between
the numbers of vasotocin cell bodies and the change in seasonal sex steroid
concentrations. While they did observe an increase in certain cell bodies in females
during the time of egg-laying, the numbers of many other cell bodies in the female and
male brain did not change. These results indicated that the number of AVT cell bodies
may be more heavily dependent on the dimorphic differences in the basal levels of sex
steroids produced between genders (8).
Other studies have been conducted to determine the relationship between
vasotocin and sex steroids. In the North American bullfrog (Rana catesbeiana), a
possible relationship was observed (10, 26). After gonadectomy, vasotocin
concentrations dropped within certain brain regions in both males and females including
the amygdala, septal area, and habenula. Concentrations of vasotocin dropped within
certain brain regions specifically in the male including the optic tectum, torus
semicircularis and pretrigeminal nucleus. The replacement of dihydrotestosterone (DHT)
restored concentrations of vasotocin in all six brain regions while replacement of
estradiol restored concentrations of vasotocin only in the amygdala, septal area, and
habenula. This indicated that sex steroids controlled vasotocin synthesis and/or its
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release. Therefore, dimorphic differences in vasotocin secretion are likely as a result of
the particular sex steroids produced in each gender.
The localized receptors of sex steroids have been thoroughly examined in
amphibians using immunocytochemistry (35) and autoradiography (36-38). While these
studies indicated that there is partial overlap between the location of sex steroid receptors
and vasotocin receptors, many authors suggested that the overlap was not complete. This
has indicated that many, but not all of the locations of vasotocin receptors are influenced
by sex steroids but that a clear relationship has not yet been defined.
These studies have demonstrated a partial relationship between AVT and
endogenous sex steroids. Studies to date offer compelling evidence for and against the
relationship between the numbers of AVT cell bodies and receptors being dependent on
the concentration of particular steroids. As with most sex steroids, there have been
differences observed between genders and species of amphibians. Therefore, there is
much to learn about how arginine vasotocin modulates reproduction and how it
particularly affects each species of amphibian.

Study Species

Boreal Toad
The boreal toad, Bufo boreas boreas, is a species located within the southern
Rocky Mountain region. Populations can be found from Wyoming and extend south
through Colorado to New Mexico (39). These toads typically reside at altitudes between
2,286 and 3,658 meters and inhabit a multitude of wet habitats including marshes, wet
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meadows, ponds and streams. Males typically grow to a length between 6.1 to 8.2
centimeters while females can grow between 7.6 and 10.2 centimeters. Both genders
typically exhibit a light mid-dorsal stripe, warty skin and oval parotid glands. Skin
coloring can vary between dark brown, black or olive.
The boreal toad’s natural breeding season begins after the species emerges from
hibernation. This occurs after snowmelt and can start as early as May in lower altitudes
or later in July. Females typically deposit eggs in shallow waters. The number of eggs
deposited depends on individual physical condition, and can vary between 3,200 to over
10,800 eggs per clutch. Females may also skip one to three years of breeding depending
on their physical condition. Male boreal toads differ from many Bufonidae species in
that they lack a vocal sac and therefore cannot produce any mating calls. Boreal toads
develop slowly with first breeding occurring at 6 years of age in females and 4 years in
males. The approximate life expectancy for this species of toad extends up to 12 years of
age in the wild. Toads may live longer if housed in captivity (39).

Fowler’s Toad
The Fowler’s toad, Bufo fowleri, is a common species from the eastern region of
the United States (40). Populations can extend from the Gulf Coast up to the northern
shore of Lake Erie in Canada. This species typically inhabits wooded areas, river valleys,
flood plains and can also be found in residential areas. Toads grow to variable sizes,
ranging from 2 inches to a maximum of 9.5 centimeters. Although there is variation in
physical appearance between locations, many exhibit a light mid-dorsal stripe and warty
skin. Fowler’s toads are usually brown, grey, or olive green with some possessing a
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single dark breast spot on the chest. The approximate life expectancy for this species of
toad extends up to 5 years of age in the wild. Toads may live longer if housed in
captivity.
The Fowler toad’s natural breeding season occurs during warmer seasons,
typically around May or June. Typical breeding sites include bodies of water that lack a
strong current. These can include marshes, ponds, lakes, and reservoirs. Fowler’s toads
develop more rapidly as compared to boreal toads, with both sexes reaching sexual
maturity at around two years of age. During breeding, males produce loud mating calls
similar to the sound of a fire alarm. Females can deposit up to 7,000 to 10,000 eggs in
one clutch (40).
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CHAPTER 3
MATERIALS AND METHODS

Experimental Design
We designed a project, comprised of three independent studies, to examine the
effects of AVT on reproductive behaviors in two species of anurans, B. fowleri and B.
boreas boreas. The first study focused on observing the effects of arginine vasotocin
when administered at multiple concentrations to either males, females, or to both genders.
While many studies have examined the effects of administering AVT to male
amphibians, many have not included an examination of AVT when administered to
females. Even fewer have examined the effects of AVT when administered to both males
and females simultaneously. In this manner, the effects of AVT administration were
differentiated between responses that came as a result of male stimulation as compared to
female stimulation as well as the combined effects of both male and female stimulation.
The second study of the experiment examined the effects of administering a
biologically high dose of AVT to both male and females as compared to previous dosages
in the first study. Study 1 showed that the best response to AVT administration resulted
when both male and females were administered the highest concentration of AVT (10.0
µg/g body weight). In order to determine if this was the optimal concentration of AVT, a
biologically high concentration (25.0 µg/g body weight) was administered to both the
20

male and female of a paring. The focus of this study was to see if a higher dose would
elicit an even greater or diminished behavioral response.
The third study was a preliminary project designed to observe the effects of
arginine vasotocin on male spermiation. The optimal AVT concentration (10.0 µg/g),
determined from study 1, was administered to male B. boreas boreas and male B. fowleri
and the effects on spermiation evaluated.

Animals
Male and female B. fowleri were collected in Memphis, Tennessee, USA and
Starkville, Mississippi, USA. Male and female B. boreas boreas were attained from the
Native Aquatic Species Restoration Facility in Alamosa, Colorado. This investigation
was approved by Mississippi State University’s Institutional Animal Care and Use
Committee.
B. boreas boreas were attained in October, 2010 whereas B. fowleri were
obtained in April/May 2010. The average age of the boreal toad subjects used in this
investigation was between 11-12 years. The exact age of the Fowler’s toad subjects are
not known, but the toads are determined to be at least sexually mature due to the nature in
which they were collected. Males were located in the wild by calling and females were
located by finding amplexed pairs. The display of calling and amplexus indicated that
the toads were of sexual maturity and were at least 2 years old when collected. These
subjects were collected between 1-3 years ago and are therefore between 3-5 years old.
Both species were housed long-term in 46 x 66 x 31 cm polycarbonate tanks, positioned
at a 15° angle and supplied with 2.5 cm aged tap water (water that has been allowed time
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to dechlorinate) in the deep end of the tank. Moistened moss was supplied as well as
plastic tubing and artificial fauna for enrichment. Room temperature was maintained
between 21-23°C. Artificial lighting was supplied using UVB bulbs (Zilla) set on a timer
to follow natural seasonal profiles of the B. boreas boreas habitat. Toads were fed
vitamin enriched crickets dusted with calcium supplement (ReptoCal) and mealworms.
The average B. boreas boreas male weight used in studies 1 and 2 was 38.44 ± 8.20
grams and the average female weight was 43.09 ± 8.30 grams. In addition, the average
B. fowleri male weight used in studies 1 and 2 was 30.50 ± 5.00 grams and the average
female weight was 37.58 ± 9.76 grams.

Study 1
Arginine vasotocin (Arg8-Vasotocin acetate salt-V0130; Sigma-Aldrich, St. Louis
MO) was resuspended in 200 µL of 1X phosphate buffered solution (PBS, 2.68 mM KCl,
1.47 mM KH2PO4, 136.89 mM NaCl, 8.1 mM Na2HPO4) and administered at four
different concentrations, 0.1, 1.0, 5.0 and 10.0 µg/g body weight. Toads were weighed
prior to hormone administration and the dose administered was adjusted accordingly.
Injections were given intraperitoneally following suggested protocol of the AZA
Amphibian Husbandry Resource Guide (45). A treatment of PBS only (200 µL) was also
administered to serve as a control. Each of the AVT concentrations was administered in
one of three different combinations. Male and female toads were divided into single
male:female groups. The first combination administered AVT to males only of each
group. The second combination administered AVT to just the female. The last
combination administered AVT to both the male and female of each group. During each
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trial the AVT concentration was administered to the appropriate individual(s) (the male,
female, or both) of the two pairs of toads. Trial days were randomized so as to help
eliminate any compounding effects. Males were paired with the same females each trial
day in order to minimize the effects of mate choice between individuals. Trial days were
conducted at least 1.5 weeks apart so as to allow the effects of hormone to diminish. By
completion of this study, each pair of male:female toads underwent every trial of each
AVT treatment in all three combinations. To help illustrate the design of this study, table
3.1 depicts an example of the treatment procedure for two pairs of toads.
This study was completed during the months of June, 2011 through January,
2012. Toads were housed in bisected 69L plastic tubs (58 x 43 x 41 cm) with each
division 29 x 43 x 41 cm, such that multiple trials could be run. Toads were paired into
single male:female groups and one pair was placed into each half of container (figures
3.1, 3.2). Each half of the plastic tub was supplied with moist 18 x 23 cm towelettes,
dampened using aged tap water. Red fluorescent bulbs were used to supply lighting and
the temperature was maintained between 21-23°C.
The following behaviors were recorded: number of males that called, time to male
calling post administration (PA), call frequency, the number of pairs that amplexed, time
to amplexus PA, and time to amplexus after the start of male calling. Other behaviors,
such as female phonotaxis and egg deposition, were also noted. We also recorded if a
female exhibited male-like behavior by attempting to amplex the male toad.
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Table 3.1
Example of Study 1 Experimental Design

1
Only
Male
Treated

0.1
1 2
1 2

1.0

1
1

Trial Day

2
Only
Female
Treated
3
Both
Treated

Treatment (AVT µg/g)
5.0
10.0

1
1

Control

2
2

2
2

1
1

4
Only
Female
Treated
1
1

5
Only
Male
Treated

2
2

2
2

Table shows example of the experimental design for two pairs of toads: male one and
female one ( 1 1), male two and female two ( 1 1). One of three combinations of
AVT were administered to each pair during a trial day (only male treated, only female
treated, both male and female treated). During each trial day, each of the four different
concentrations of AVT were administered (0.1, 1.0, 5.0 or 10.0 µg/g AVT). The trial
days and concentrations were randomized. By the end of the study, each pair of toad had
undergone treatment at each concentration in every combination.
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Call frequency was recorded by measuring the number of times in which a male
called/minute on an hourly basis within the first five hours after call start. Frequency
measurements did not begin until after the male began calling. Call frequency was not
recorded and included in analyses if the male never called, or if the male was amplexing
a female, as males typically cease calling after initiation of amplexus. Recording call
frequency using this method ensured that the analyzed measurements only included data
from males during periods of calling. The data does not include other call characteristics,
such as duration, that may have also been impacted.
Video monitoring was used to record behaviors following hormone
administration. After AVT injections, behaviors were recorded for 24 hours using the
HandiAVI computer program, motion-activated videography (Anderson’s AZcendant
Software, Tempe, AZ). Video footage was recorded at 100% quality and 80%
sensitivity. Video was captured using Logitech webcams, 5 megapixel photo, 1280 x 720
pixel video capture, USB 2.0 (Logitech, Fremont, CA).
During this study, certain combinations did not elicit any behavioral responses.
Because of this, these combinations were discontinued after what was determined as
sufficient number of trials. In the B. boreas boreas species, a total sample size of 4 pairs
(4males:4males) were administered AVT at all concentrations in each of the three
combinations (only male injected, only female injected, both male and female injected).
In the B. fowleri species, a total sample size of n= 4 pairs (4males:4females) were
administered AVT at all concentrations in the combination in which only the females
were injected. A total sample size of n= 10 pairs (10males:10females) were administered
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AVT at all concentrations in the combinations which injected either the male only of a
group, or both the male and female.

Study 2
Upon completion of Study 1, we chose the best AVT treatment that gave the
optimal reproductive behavioral responses, (10.0 µg/g, to both the male and female) to
further examine the effects of AVT. Study two was designed to determine whether 10.0
µg/g was the optimum concentration of AVT or if a higher dose could attain even greater
behavioral responses. In both the B. boreas boreas and B. fowleri species, a total sample
size of 6 pairs (6 males:6 females) were administered 25.0 µg/g AVT. In order to
compare the results to the previous study, 6 pairs were also administered 10.0 µg/g AVT.
As a control, 6 pairs of toads were administered 200 µL of PBS only. Toads were paired
randomly in each trial and placed into the same containers as in study 1; however, plastic
tubs were placed at a 14° angle and supplied with approximately 2.5 cm of aged tap water
at deep end. Toads were housed in this manner so as to allow females direct access to
water for egg deposition. Behaviors were also recorded in the same manner as study 1.
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Figure 3.1. Photograph of Housing for Study 1.
Video footage recorded using Logitech webcams via HandAVI computer program. Red
lamps used to supply lighting.

Figure 3.2. Photograph of Housing for Study 1.
Video footage recorded using Logitech webcams via HandAVI computer program. Red
lamps used to supply lighting.
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Study 3
To determine the effects of AVT on male spermiation, a preliminary study was
done to see if the 10.0 µg/g AVT administered to three male B. boreas boreas and three
male B. fowleri caused sperm release. The average B. boreas boreas male weight in this
study was 36.00 ± 1.00 grams (n=3). The average B. fowleri male weight was 34.33 ±
5.51 grams (n=3). Toads were housed in 18 x 33 x 10.2 cm plastic containers and
supplied with 1.25 cm aged tap water to ensure hydration.
Prior to hormone administration, urine was collected from all males to determine
the presence/absence of sperm. Spermic urine samples were collected at 30 min, 1, 3, 5,
7 and 24 hours after hormone administration (±10 min). To attain urine samples, toads
were suspended over 150 mm petri dishes with legs held apart. If males did not urinate
within 2 minutes following this method, then a small plastic catheter (flame polished and
cooled) was inserted into their cloacal opening and used to gently attain urine from the
bladder. Samples were analyzed for the presence of sperm using a Nikon microscope, at
200X magnification. Data collected at each time point included the number of toads that
responded, sperm concentration, motility, and forward progressive movement (FPM).
FPM represented a subjective measure of how well spermatozoa were able to move in a
forward direction. It was graded on a scale of 0-5, 0 representing no forward movement
and 5 representing maximum forward movement. Sperm concentration was measured
using a Neubauer hemacytometer.
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Statistical Analyses
Behaviors displayed during the first two studies of this investigation were
compared between treatments (0.1, 1.0, 5.0, 10.0 and 25.0 µg/g AVT) and in the
combination in which they were administered: 1) male only of a pair was treated, 2) just
the female was treated and 3) both male and female were treated. Behaviors were
compared using covariate analysis, PROC GLIMMIX. Analyses were performed using
SAS 9.2, 2009. Data was evaluated over time using general linear mixed model covariate
analyses with a pseudo maximum likelihood indicator to treat for unequal sample sizes.
Responses were considered significant at P values <0.05. The linear responses to the
combinations and concentrations of AVT treatment and time were analyzed as well the
interactive effects of these parameters. Averaged response values are displayed as mean
± standard error of mean (SEM).
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CHAPTER 4
RESULTS

Study 1. Effects of Arginine Vasotocin on Reproductive Behaviors in B. Boreas
Boreas
Boreal toads exhibited no behavioral response to any AVT treatment. This
included administration of AVT in each of the three different pairings (male only, female
only, or both) or with any treatment concentrations (0.1, 1.0, 5.0 and 10.0 µg/g).
Furthermore, no behavioral response was observed in control animals treated with 200
µL PBS.

Study 1. Effects of Arginine Vasotocin on Reproductive Behaviors in B. Fowleri
There was no amplexus or calling behavioral response in the treatments in which
only the female B. fowleri was administered AVT including treatments at each
concentration (0.1, 1.0, 5.0 and 10.0 µg/g) as well as the control treatment (200 µL PBS).
Moreover, no behavioral response was observed in control treatments when administered
in the other combinations (male only or both male and female). However, behavioral
responses were attained when AVT was administered to the male only or to both the male
and female of a group.
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Calling Behavior
10 pairs of toads (paired into single male:female groups) were administered AVT
in the following concentrations: 0.1, 1.0, 5.0 and 10.0 µg/g. In both of the combinations,
a) male only or b) both the male and female, the greatest number of males displayed
calling when administered either 5.0 or 10.0 µg/g AVT. When only males were
administered AVT, 90% responded at 5.0 and 10.0 µg/g (figure 4.1). When both the
male and female were administered AVT, 90% of the males responded at 5.0 µg/g and
100% responded at 10.0 µg/g AVT (figure 4.1). In both combinations, the concentration
of AVT administered significantly affected call frequency during the first five hours
(p<0.0294). Also, the frequency of calling significantly differed between each of the five
hours after calling started (p<0.0001), with the frequency highest during the first hour
and diminishing over time (figures 4.4, 4.5) The combination in which AVT was
administered did not significantly impact call frequency (p<0.1829, figures 4.4, 4.5).
There was also no significant interactive effect between the combination and
concentration (p<0.7072), combination and time (p<0.1798) or concentration and time
(p<0.4050) of AVT.
There were no significant differences between the AVT combinations (p< 0.3980)
or concentrations (p< 0.2242) on how quickly the male began calling post administration
(figure 4.6). There was also no significant interactive effect between the combination
and concentration (p<0.2434) in which AVT was administered. When both male and
female were injected, it took 44.44 ± 9.246 min on average for the male to start calling
(averaged between all concentrations). It took 58 ± 14.531 min on average when only the
male was administered AVT (figure 4.6).
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Figure 4.1. Percentage of B. Fowleri Males Calling Following Administration of
Arginine Vasotocin (AVT).
Males were paired with a single female and treated with either 0.1, 1.0, 5.0 or 10.0 µg/g
AVT in one of three different combinations: only males treated, only females treated,
both males and females treated.
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Figure 4.2. Number of B. Fowleri Males which Continued to Call in the Treatment in
which Both Male and Female Toads were Administered Arginine Vasotocin
(AVT).
Toads were administered either 0.1, 1.0, 5.0 or 10.0 µg/g AVT with a total sample size of
n= 10 pairs in each concentration treatment.
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Figure 4.3. Number of B. Fowleri Males which Continued to Call in the Treatment in
which Only the Males were Administered Arginine Vasotocin (AVT).
Male toads were administered either 0.1, 1.0, 5.0 or 10.0 µg/g AVT with a total sample
size of n= 10 pairs in each concentration treatment.
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Figure 4.4. Average B. Fowleri Male Call Frequency of Treatments in which Both Male
and Female Toads were Administered Arginine Vasotocin (AVT).
Call frequency was recorded during the first five hours after males began calling. Toads
were treated with either 0.1, 1.0, 5.0 or 10.0 µg/g AVT. The control treatment did not
stimulate any males to call and therefore is not shown in the graph. The concentrations of
AVT administered had a significant effect on the frequency of calling (p<0.0294) as well
as time (p<0.0001), with overall frequency decreasing with time. There were no
significant differences between the AVT combinations (p<0.1829), nor was there a
significant interactive effect between the AVT combination and concentration
(p<0.7072), AVT combination and time (p<0.1798) or AVT concentration and time
(p<0.4050).
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Figure 4.5. Average B. Fowleri Male Call Frequency of Treatments in which Only the
Males were Administered Arginine Vasotocin (AVT).
Call frequency was recorded during the first five hours after males began calling. Male
toads were treated with either 0.1, 1.0, 5.0 or 10.0 µg/g AVT. The control treatment did
not stimulate any males to call and therefore is not shown in the graph. The
concentrations of AVT administered had a significant effect on the frequency of calling
(p<0.0294) as well as time (p<0.0001), with overall frequency decreasing with time.
There were no significant differences between the AVT combinations (p<0.1829), nor
was there a significant interactive effect between the AVT combination and concentration
(p<0.7072), AVT combination and time (p<0.1798) or AVT concentration and time
(p<0.4050).
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Figure 4.6. Average Time for B. Fowleri Males to Begin Calling Following
Administration of Arginine Vasotocin (AVT).
Male toads were treated with either 0.1, 1.0, 5.0 or 10.0 µg/g AVT. The combination in
which only females were administered AVT did not stimulate any males to call and
therefor is not included in this graph. Both of the control treatments and one of the 0.1
µg/g treatments in the other combinations did not stimulate any males to call and
therefore are also not shown in the graph. There were no significant differences between
the AVT combinations (p< 0.3980) or concentrations (p< 0.2242) on how quickly the
male began calling, nor was there a significant interactive effect between the AVT
combination and concentration (p<0.2434).
Amplexus Behavior
The greatest amplexus response was attained when both the male and female were
administered AVT (figure 4.7). Seventy percent of the pairs amplexed when both male
and female were administered 5.0 µg/g AVT and 60% when administered 10.0 µg/g
AVT. Only 30% of the pairs exhibited amplexus when only the males were administered
either 5.0 or 10.0 µg/g AVT (figure 4.7).
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The combination in which AVT was administered significantly affected the length
of time in which a pair remained amplexed (p<0.0347; figure 4.8). On average, a pair
remained amplexed for 829.65 ± 149.10 minutes when both the male and female were
administered AVT compared to 265.95 ± 202.02 minutes when only the male was
administered AVT (averaged across concentrations administered). The concentrations in
which AVT was administered significantly affected the length of time pairs remained
amplexed in both combinations (p<0.0429). Pairs remained amplexed longest when both
male and female were administered 10.0 µg/g AVT at 1319.20 ± 58.526 minutes
compared to other concentrations in this combination as well as all concentration
treatments in the combination in which only males were injected. When only the male
was administered AVT, pairs remained amplexed longest when administered 5.0 µg/g
AVT at 599 ± 427.113 minutes (figure 4.8) as compared to other treatments in this
combination. There was no significant interactive effect between the combination and
concentration (p< 0.1928) in which AVT was administered.
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Figure 4.7. Percentage of B. Fowleri Pairs that Amplexed Following Treatments of
Arginine Vasotocin (AVT).
Male and female toads were divided into single male:female groups and administered
either 0.1, 1.0, 5.0, or 10.0 µg/g AVT in one of the following combinations: only males
treated, only females treated, both males and females treated. The numbers above each
bar signify the number of pairs which displayed amplexus/pairs administered AVT.
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Figure 4.8. Average Length of Time B. Fowleri Pairs Remained Amplexed.
Male and female toads were divided into single male:female groups and administered
either 0.1, 1.0, 5.0, or 10.0 µg/g AVT in one of the following combinations: only males
treated, only females treated, both males and females treated. The numbers above each
bar signify the number of pairs which continued to display amplexus/pairs administered
AVT. The combination in which only females were administered AVT did not stimulate
any amplexus behavior and is therefore not displayed. The 0.1 µg/g and control
treatments also did not have any pairs amplex and are therefore not displayed. The
combination (p<0.0347) and concentration (p<0.0429) significantly affected the length in
which a pair remained amplexed; however, there was no significant interactive effect
between the two factors (p<0.1928).
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There was no significant effect between the combinations (p< 0.9159) or
concentrations (p< 0.4018) of AVT treatment on how quickly pairs amplexed after
administration, nor was any significant interactive effect between the AVT combination
and concentration (p< 0.2836; figure 4.9). When both male and female were
administered AVT, pairs amplexed 121.10 ± 38.275 min on average post administration
(averaged between all concentrations). Pairs amplexed 116.06 ± 50.216 min on average
when only the male was administered AVT (figure 4.9).
There was also no significant effect between the combinations (p< 0.7485) or
concentrations (p< 0.3116) of AVT administrated on how quickly pairs amplexed after
the male started calling (figure 4.10). There was also no significant interactive effect
between the combination and concentration (p< 0.5795) in which AVT was administered.
When both male and female were administered AVT, pairs amplexed 75.31 ± 26.954 min
on average after call start (averaged between all concentrations). Pairs amplexed 92.55 ±
49.993 min on average when only the male was administered AVT (figure 4.10).

Other Behaviors
Other behaviors such as phonotaxis, egg deposition and male-like behaviors were
observed in the treatment combination where both the male and female were
administered AVT. Phonotaxis was observed twice when both male and female were
administered 10.0 µg/g AVT and twice when administered 5.0 µg/g AVT (table 4.1).
Females that displayed male-like behavior, did so twice when both male and female were
administered 5.0 µg/g AVT and twice when administered 10.0 µg/g AVT (table 4.1).
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Two females deposited eggs during study 1. One female deposited eggs when 5.0 µg/g
AVT was administered to both male and female. Egg deposition began 17 hours post
administration, 10 hours after amplexus began. Another female deposited eggs when
both male and female were administered 10.0 µg/g AVT. Egg deposition began 18 hours
post administration, 16 hours after amplexus began (table 4.1). Both clutches of eggs
appeared normal.

Study 2. Effects of Arginine Vasotocin High Dose on Reproductive Behaviors in the
B. Boreas Boreas
There was no calling or amplectic response observed in the boreal toad species to
any AVT treatment. This includes administration of AVT to both males and females at
each concentration (10.0 and 25.0 µg/g). In addition, none of the boreal toads displayed a
behavioral response to the control treatment (200 µL PBS).

Study 2. Effects of Arginine Vasotocin High Dose on Reproductive Behaviors in the
B. Fowleri

Calling Behavior
Six pairs of toads were administered 10.0 µg/g AVT and another six pairs 25.0
µg/g with males and females treated simultaneously. Five males (83%) called when
administered 10.0 µg/g AVT compared to all 6 males (100%) that called in the 25.0 µg/g
treatment group (figure 4.11)
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There was no significant difference in call frequency between treatment groups
(p<0.2530; figure 4.13). The frequency of calling significantly differed between each of
the five hours after calling started (p<0.0197), with the frequency of calling highest
during the first hour and diminishing over time. On average, the frequency of calling
during the first hour was 3.33 ± 0.360 calls/min in the 10.0 µg/g treatment group and 2.82
± 0.476 calls/min in the 25.0 µg/g treatment (figure 4.13).

Figure 4.9. Average Time for B. Fowleri Pairs to Begin Amplexus Following
Administration of Arginine Vasotocin (AVT)
Male and female toads were divided into single male:female groups and administered
either 0.1, 1.0, 5.0, or 10.0 µg/g AVT in one of the following combinations: only males
treated, only females treated, both males and females treated. The combination in which
only females were administered AVT did not stimulate any amplexus behavior and is
therefore not displayed. The 0.1 µg/g and control treatments also did not have any pairs
amplex and are therefore not displayed. There was no significant effect between the
combinations (p< 0.9159) or concentrations (p< 0.4018) of AVT treatment on how
quickly pairs amplexed after administration, nor was there was any significant interactive
effect between the AVT combination and concentration (p< 0.2836).
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Figure 4.10. Average Time for B. Fowleri Pairs to Begin Amplexus Following the Start
of Male Calling.
Male and female toads were divided into single male:female groups and administered
either 0.1, 1.0, 5.0, or 10.0 µg/g arginine vasotocin (AVT) in one of the following
combinations: only males treated, only females treated, both males and females treated.
The combination in which only females were administered AVT did not stimulate any
amplexus behavior and is therefore not displayed. The 0.1 µg/g and control treatments
also did not have any pairs amplex and are therefore not displayed. There were no
significant differences between the combinations (p< 0.7485) or concentrations (p<
0.3116) of AVT administrated on how quickly pairs amplexed after the male started
calling, nor was there was any significant interactive effect between the AVT
combination and concentration (p< 0.5795).
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Table 4.1
Other Behaviors Observed in Study 1 Following Arginine Vasotocin (AVT)
Administration.

Concentration

5 µg/g AVT

10 µg/g AVT

Phonotaxis

2 females

2 females

Male-like behavior
(Female amplexed
male)
Egg Deposition

2 females

2 females

1 female (~3,000 eggs)

1 female (3,712eggs)

All observed when both male and female administered arginine vasotocin (AVT).

Figure 4.11. Percent of B. Fowleri Males Calling Post Administration.
Both male and female toads were treated with either 10.0 µg/g or 25.0 µg/g arginine
vasotocin (AVT). Numbers inside bars signify the number of males that displayed calling
vs. males administered AVT.
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Figure 4.12. Number of Males which Continued to Call Following Arginine Vasotocin
(AVT) Administration for B. Fowleri During the First Five Hours.
Both male and female toads were treated with either 10.0 µg/g or 25.0 µg/g AVT, with
total sample size of n= 6 males treated.
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Figure 4.13. Average Male Call Frequency Following Arginine Vasotocin (AVT)
Administration for B. Fowleri During the First Five Hours After Males
Began Calling.
Both male and female toads were treated with either 10.0 µg/g or 25.0 µg/g AVT. The
control treatment did not stimulate any males to call and therefore is not shown in the
graph. There was no significant difference between treatment groups (p<0.253); however,
time did have a significant effect on call frequency (p<0.0197) with the frequency
decreasing over time.
There was no significant difference between the concentrations of AVT
administrated on how quickly the male began calling post administration (p<6.174; figure
4.14). When treated with 10.0 µg/g, males began calling 26.00 ± 9.375 min after
administration compared to 35.67 ± 15.070 min for the 25.0 µg/g treatment (figure 4.14).

Amplexus Behavior
Subsequent to administration of high AVT concentrations, a portion of B. Fowleri
toad pairs exhibited amplexus. Five pairs amplexed in the 10.0 µg/g (83%) treatment
group whereas only 3 pairs (50%) amplexed in the 25.0 µg/g treatment (figure 4.15).
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There were no significant differences between the concentrations of AVT administered
on time to amplexus post administration (p<0.694; figure 4.16), time to amplexus after
calling started (p<0.515; figure 4.17) and length of amplexus (p<0.732, figure 4.18).
In the 10.0 µg/g AVT treatment group, pairs amplexed 63.20 ± 18.919 minutes on
average post administration compared to 35.67 ± 21.079 minutes in the 25.0 µg/g
treatment. On average, pairs amplexed 40.00 ± 19.362 minutes after calling started in the
10.0 µg/g treatment as compared to 20.33 ± 16.344 minutes in the 25.0 µg/g treatment.
Male-female pairs treated with either 10.0 µg/g or 25.0 µg/g AVT remained amplexed for
828.20 ± 335.306 or 1018 ± 388.012 minutes, respectively.

Figure 4.14. Average Time for B. Fowleri Males to Begin Calling Following
Administration of Arginine Vasotocin (AVT).
Both male and female toads were treated with either 10.0 µg/g or 25.0 µg/g AVT. The
control treatment did not stimulate any males to call and therefore is not shown in the
graph. There was no significant difference between treatment groups (p<6.174).
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Figure 4.15. Percentage of B. Fowleri Pairs that Amplexed Following Treatments of
Arginine Vasotocin (AVT).
Numbers inside bars signify the number of pairs which displayed amplexus/pairs
administered AVT. Both male and female toads were treated with either 10.0 µg/g or
25.0 µg/g AVT.
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Figure 4.16. Average Time for B. Fowleri Pairs to Begin Amplexus Following
Administration of Arginine Vasotocin (AVT).
Male and female toads were treated with either 10.0 µg/g or 25.0 µg/g AVT. The control
treatment did not have any pairs amplex and therefore is not shown in the graph. There
was no significant difference between treatment groups (p<0.694).
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Figure 4.17. Average Time for B. Fowleri Pairs to Begin Amplexus Following the Start
of Male Calling.
Both male and female toads were treated with either 10.0 µg/g or 25.0 µg/g AVT. The
control treatment did not have any pairs amplex and therefore is not shown in the graph.
There was no significant difference between treatment groups (p<0.515).
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Figure 4.18. Average Length of Time B. Fowleri Pairs Remained Amplexed.
Both males and females were treated with either 10.0 µg/g or 25.0 µg/g AVT. The
control treatment did not have any pairs amplex and therefore is not shown in the graph.
There was no significant difference between treatment groups (p<0.732).

Other Behaviors
Other behaviors such as phonotaxis and egg deposition were observed in the
second study. Phonotaxis was observed once and male-like behavior twice in both
treatment groups. One female deposited eggs in the 25.0 µg/g AVT treatment group
while two females deposited eggs in the 10.0 µg/g AVT treatment (table 4.2). All egg
clutches appeared immature (figure 4.19). The female that deposited eggs in the 25.0
µg/g treatment did so 40 hours post administration. As compared to the other females
which remained amplexed until egg deposition began, this female was only amplexed for
4 hours during the 24hr trial. Egg deposition began 33 hours after amplex stopped.
When treated with 10.0 µg/g AVT, one female deposited eggs 15hr post administration,
14hr after amplexus began and the other female deposited eggs 19hr 30min post
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administration, 19hr 20min after amplexus began. Egg clutches deposited in the 10.0
µg/g AVT treatment were separated into 100 egg groupings and fertilized with spermic
urine (100 µL spermic urine containing ~100,000 spermatozoa administered to each egg
grouping). Eggs were then assessed 4 hours post administration. Partial cleavage was
observed in many of the eggs, indicative of auto-activation, but none had successfully
developed into 2 and 4-cell stage embryos (figure 4.19).
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Table 4.2
Other Behaviors Observed in Study 2 Following Arginine Vasotocin (AVT)
Administration.

Phonotaxis

Male-like Behavior

Egg Deposition

(Female amplexed male)
10 µg/g AVT

1 female

2 females

2 females
Clutch 1: 3,056 eggs
Clutch 2: ~3,000eggs.

Treatment

Separated clutches into
100 egg groupings. Each
grouping fertilized with
100 µL spermic urine
containing
approximately 100,000
spermatozoa. Assessed
eggs 4hr post spermic
urine administration. No
successful development
into 2-cell/4-cell stage
occurred.

25 µg/g AVT

1 female

2 females

1 female: 3,181 eggs

Treatment
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Figure 4.19. Photograph of Eggs 4 Hours After Spermic Urine Administered (100µL of
Sermic Urine, with Approximately 100,000 Spermatozoa).
Egg clutch deposited from female receiving 10.0 µg/g arginine vasotocin treatment in the
combination with both male and female injected. There was no successful embryo
development in this batch. Note that many eggs display partial cleavage, an indication of
auto-activation. It is possible that these eggs were immature and therefore unable to
successfully undergo fertilization and development.
Toad Mortality
Six B. fowleri toads died shortly after participating in study 2 of the investigation.
Information regarding the timing and dose of AVT administration, prior to mortality, is
depicted in table 4.3. Each of these toads had recently received (within 6-21 days) one of
the two highest doses of AVT, 10.0 and/or 25.0 µg/g. All of the subjects had been
administered 10.0 µg/g AVT at least once throughout the first study of the investigation;
however, the treatment days in which the higher concentration was administered were
spaced farther apart by treatment days of lower concentrations (0.1, 1.0, or 5.00 µg/g
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AVT or the control treatment of just 200µL PBS). In comparison to study 1, the second
study had many subjects receiving one of the two higher doses consecutively between
treatment days. Both of the females had been used in previous years for hormone studies
that examined the effects of exogenous hormone administration on the induction of egg
development and deposition. In a non-related study, female one had been hormonally
induced to deposit three clutches of eggs during August 2010- June 2011 with each
deposition spaced 4 months apart. The egg deposition which occurred during our study 2
was the fourth time she was induced to deposit eggs within an 18 month period.
Mortality occurred 6 months after her previous deposition. Female two had been
hormonally induced to deposit eggs twice during August 2010- April 2011, spaced 8
months apart. Female two did not deposit eggs during this investigation. The rate of
mortality previously mentioned is higher than typically observed in the colony. Within
the time that these toads have been housed at Mississippi State University, the typical rate
of die off is approximately one toad per two month span. Except for the observation of
lethargy and weight loss, there were no other symptoms observed prior to death.

Study 3. Effects of Arginine Vasotocin on Spermiation in B. Boreas Boreas
As a preliminary trial, AVT was administered to three male boreal toads at the
concentration of 10.0 µg/g. Urine was collected prior to hormone administration in all
three toads and observed to have no sperm. After AVT administration, there was no
urine output from all three toads at 30 minutes, 1, 3, 5 and 7 hours post administration.
Thus, sperm analyses were not able to be conducted at these time points. One toad
produced a urine sample 24 hours post administration with no sperm present. Hence, we
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were not able to determine if AVT induced spermiation in Boreal toads and this should
be evaluated in the future with more animals and different concentrations.

Study 3. Effects of Arginine Vasotocin Spermiation in B. Fowleri
AVT was administered to three male Fowler’s toads at the concentration of 10.0
µg/g. As previously mentioned, urine was collected prior to hormone administration and
observed to be devoid of sperm. After AVT administration, there was no urine output
from all three toads at 30 minutes, 1 and 7 hours post administration. Thus, sperm
analyses could not be conducted at these time points. However, urine samples were
collected from all three males at 3, 5 and 24 hours post administration. No sperm was
present in any of the collected samples.
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Table 4.3
Bufo Fowleri Toad Mortality

Last AVT Doses

Previous AVT Dose

Comments

Female 1

25.0 µg/g AVT. Administered
20 days prior to death.
(Administered just 200µL PBS
13 days later. Died 7 days after
this treatment.).

0.1 µg/g. Administered 41 days
prior to last AVT dose.

Female 2

25.0 µg/g AVT. Administered
21 days prior to death.

1.0 µg/g AVT. Administered
11 days prior to last dose.

Male 1

25.0 µg/g AVT. Administered
18 days prior to death.

10.0 µg/g AVT. Administered
19 days prior to last dose.

Male 2

10.0 µg/g AVT. Administered
18 days prior to death.

10.0 µg/g AVT. Administered
19 days prior to last dose.

Deposited eggs 2
days after
administration of
AVT. Appeared
lethargic after egg
deposition until
death. Otherwise
no physical
abnormalities or
weight loss.
Appeared normal
until death. No
weight loss. Had no
obvious physical
abnormalities.
Appeared lethargic
10 days prior to
death, but otherwise
no obvious physical
abnormalities. No
weight loss.
Experienced weight
loss (Start wt.=
30.6g, end wt.=
21g). Would not
voluntarily eat.
Force fed 3 days
prior to death.

Male 3

10.0 µg/g AVT. Administered
6 days prior to death.

No previous AVT treatments.

Male 4

10.0 µg/g AVT. Administered
9 days prior to death.

25.0 µg/g. Administered 13
days prior to last dose.
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Appeared lethargic,
but otherwise no
obvious physical
abnormality. No
weight loss.
Appeared normal
until death. No
weight loss. Had no
obvious physical
abnormalities.

CHAPTER 5
DISCUSSION

Very little is known regarding the stimulatory effects of exogenous AVT
administration when given to a female alone or to both sexes compared to if AVT is only
administered to males. We hypothesized that the female response to AVT would also be
important in mate compatibility and timing; hence, more reproductive behaviors would
be seen when both animals are treated with AVT compared to each gender alone. Our
results clearly demonstrate that AVT can have a functional role in both sexes, is
concentration dependent, and also species-specific. This study showed that two anurans
within the same taxonomic family and genus can respond very differently to AVT and
whether an anuran responds to AVT or not may depend upon the species natural
reproductive strategy.

The Behavioral Effects of Arginine Vasotocin in the Bufo Fowleri Species

Calling and Amplexus Behavior
There has been little, if any, research conducted which focused on the effects of
simultaneously stimulating both male and female amphibians with AVT. The results of
this investigation indicate that sexual stimulation of both can achieve the greatest
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reproductive response. Administering 5.0 and 10.0 µg/g AVT to both male and female B.
Fowleri toad stimulated more males to call (figure 4.1) and remain amplexed longer
(figure 4.6). To the best of the author’s knowledge, this is the first time AVT has been
reported to induce amplexus behavior in an anuran species. While there were some
calling and amplexus behaviors observed when just the male was treated, the best
response resulted when the females were administered AVT simultaneously.
Administering AVT to the females may have induced their reproductive stimulation
which could have subsequently affected male arousal. Females also displayed other
behaviors such as phonotaxis and male-like behavior (amplexing) when the male was
administered AVT. These behavioral responses suggest that the female Fowler’s toads
may also require the presence of a sexually stimulated male to elicit a reproductive
response. Similarly in the rough skinned newt (Taricha granulosa), both male and
female genders have shown breeding preference with sexually mature counterparts.
Males naturally were attracted to foam pads scented with the pheromones of unmated
females (8) and spent more time in close proximity with these pads when administered
AVT as compared to saline. Stimulated males also showed increased attraction to plastic
models of female newts that were marked with female pheromones. Similarly,
ovariectomized female newts showed increased male-like behavior when administered
AVT concomitant with DHT and testosterone (7).
These findings suggest that AVT can be administered to animals where it may be
desired to induce natural breeding behaviors. For example, the applications of exogenous
hormones have become quite useful in amphibian breeding colonies (6). Many
amphibian species will cease to display natural breeding behaviors when taken out of the
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wild and placed into captivity. In many cases, the lack of proper environmental cues is
the cause. Many programs turn to the use of exogenous hormones to overcome this
challenge. While much progress has been accomplished with the study of amphibian
reproduction, there are still challenges faced when using assisted reproductive
technologies. It is very difficult to avoid physically damaging gametes during their
manipulation and storage for later use in artificial fertilization. The damage can impair
fertilization and proper development. To avoid damage incurred by these techniques,
many breeding programs will opt for a hormone protocol that can elicit natural breeding
behaviors in both male and females. Inducing amphibians to exhibit natural breeding
allows for the production of embryos naturally without the need to handle or store sperm
and eggs. This natural method of attaining embryos may result in improved overall
viability and development of offspring.
While there were some significant effects of AVT on calling and length of
amplexus, the treatment of AVT did not have a significant effect on other parameters
including the time required for males to begin calling (figure 4.4) and pairs to begin
amplexus after AVT administration (figure 4.7) as well as the time required for pairs to
begin amplexus after males began calling (figure 4.8). Since there were no significant
effects between the different treatments of AVT, it is possible that the behavioral
responses observed in these parameters were more likely the result individual variation.
Some individual toads may naturally have been more reproductively active than others
and could therefore react more readily to the administration of AVT. For example, some
male toad species such as the Puerto Rican crested toad (Peltophryne lemur) maintain
complex social hierarchies (19). The hierarchy consists of males defined as territorial
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(calling), satellite (submissive, non-calling) and parental (males which guard and brood
embyros). While these complex hierarchies have not been observed in the B. Fowleri
species, it is possible that some males and females exert dominance over others within
the colony. Studies have observed that male and female vertebrates which display social
dominance can also produce increased levels of androgens such as testosterone (41, 42).
These hormones have been correlated with increased concentrations of AVT brain
receptors (10) and could explain how dominant toads may show increased response to
AVT administration. The individuals that showed decreased behavioral responses
(requiring more time to begin calling and amplexus) may have been submissive toads
with relatively lower production of endogenous androgens.

Egg Deposition
Five females deposited eggs during this investigation. Each egg deposition
occurred when both males and females were administered AVT simultaneously. One
female deposited eggs in the 5.0 µg/g treatment, three females in the 10.0 µg/g treatment
and one in the 25.0 µg/g treatment (tables 4.1,2). Some of the eggs appeared to be
immature and did not successfully develop after artificial fertilization (figure 4.17). The
impaired development may have been a result of premature egg deposition. AVT shares
similar physiological effects with the mammalian hormone, oxytocin (44, 29) and can
induce egg laying behavior and oviposition in the female rough skinned newt during
times of elevated estradiol. Administering AVT at these concentrations may have
stimulated the females to deposit their eggs before they could complete maturation.
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Particularly interesting, the female that deposited eggs when treated with 25.0
µg/g AVT did so 40 hours after administration. Unlike the other females, this female did
not remain amplexed long (only 4 hours). Other females remained amplexed for at least
10 to 19 hours. The female treated with 25.0 µg/g AVT may have had delayed egg
deposition because she was not tactilely stimulated by male amplexus for an extended
period of time. Another reason for the delayed ovulation without a long amplexus event
could be that AVT was administered at too high of a concentration. Administering 25.0
µg/g may have flooded the brain’s receptors and caused a down regulatory effect on
synthesis and secretion of hormones. In anuran species, these AVT receptors have been
located in torus semicirculus, preoptic area of the hypothalamus, and the pre-trigeminal
nucleus (43). It might have taken time for the female to metabolize enough of the
hormone so that the receptors may have returned to their normal active state.
Studies in the catfish (Heteropneustes fossilis) have shown improved follicle
development following in vitro culture supplemented with AVT (29). Supplementing
AVT may increase follicle hydration, improving development and ovulation. It is
possible that administering AVT at lower doses may stimulate this effect in an anuran
species as well. In this regard, it may be beneficial to examine the effects of AVT when
administered in a series of low, pre-ovulatory doses before treating with a full ovulatory
dose. Using low ovulatory doses may slowly develop the follicles to complete
maturation before being stimulated to ovulate.
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Toad Mortality
Shortly after completion of study 2, six Fowler’s toads died. While it is unclear
exactly why the toads died, it may have been due to AVT treatment. Each of these had
recently received one of the two highest doses of AVT, 10.0 and/or 25.0 µg/g (table 4.3).
It is possible these higher doses of AVT may have caused the death of these subjects or
the repeated administration may have had a toxic effect. While treatments were
administered apart by a period of at least 10 days, this may not have allowed enough time
for the effects of AVT to diminish. To the author’s knowledge, there has been no citation
of mortality after AVT administration. However, the author is also unaware of any study
that has administered as high of a dose. Administering the high doses of AVT may have
also over exerted the toads physically. The doses induced calling and amplexus
behaviors, both of which demand high energy usage from the males (44). One of the
females also died shortly after depositing eggs. While B. Fowleri females typically
deposit eggs once every year, this female had been stimulated to deposit eggs four times
within the last two years. Egg deposition requires energy expenditure from female
amphibians (45) and inducing the female to deposit eggs may have depleted too much of
her energy and caused mortality.

The Optimal Concentration of Arginine Vasotocin
The results of this investigation found that the 5.0 and 10.0 µg/g AVT treatments
stimulated the most successful breeding response in the Fowler’s toad in regards to the
number of calling males (figure 4.1), increased frequency of calling (figure 4.3a,b) and
the number of pairs which exhibited amplexus (figure 4.5). Although there was no
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significant difference in behavioral responses between 10.0 and 25.0 µg/g AVT upon
completion of the second study, the 10.0 µg/g treatment was considered preferable since
it is possible that AVT may have toxic effects, administering a lower dose could help
avoid mortality. The greatest number of pairs exhibiting amplexus was observed in the
5.0 and 10.0 µg/g AVT treatments when administered to both male and female toads.
Pairs remained amplexed longest when both were administered 10.0 µg/g AVT (figure
4.6). While there were many different parameters analyzed, the authors of this study felt
that the effects of AVT on amplexus were the most important behaviors in terms of
attaining a successful reproductive response; in particular, the number of pairs which
amplexed and the length of time in which they remained amplexed. While calling is
often an important step in the process of finding potential mates, it is the act of amplexus
that is essential to ensure the proper placement and fertilization of gametes. Since
administering 10.0 µg/g AVT stimulated a greater number of pairs to amplex and to
remain amplexed longest, it is considered the optimal dose in this investigation.
However, it is possible that combining AVT with other hormones, such as lutenizing
hormone releasing hormone (LHRH), human chorionic gonadotropin (hCG), or
corticosterone may have a synergistic effect and decrease the concentration of AVT
required to stimulate a successful reproductive response. It would be beneficial for future
studies to examine the effects of administering these hormones together with AVT as a
hormone regimen.
Previous amphibian studies that have examined AVT’s effects on reproduction
used relatively small doses. For example, doses as low as 0.001, 0.01 and 1.0 µg/g of
AVT were administered to the great plains toad (Bufo cognatus), but did not stimulate
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any amplectic response (15). Other studies have found a profound effect at very little
doses, such as 0.1µg, when administered to the male rough skinned newt (13). It is
possible that anuran species may require higher doses of AVT (such as 5-10.0 µg/g) to
stimulate an amplectic response. AVT receptors in anurans may not have been conserved
as well throughout evolution as compared to newts in the caudata order (46). Because the
receptors in anuran species may not be as evolutionarily conserved, they may not be
specific enough to react to AVT at lower doses. Anuran AVT receptors ligands may not
be specific enough to react the AVT peptide, thus needing higher doses to elicit a
reproductive response. Previous studies may not have administered high enough doses
which could be why those studies have failed to induce amplexus after administering
AVT.

The Effects of Arginine Vasotocin on Behavior in the Bufo Boreas Boreas Species
Interestingly, the administration of AVT did not elicit any behavioral response in
the boreal toad that we could observe, regardless of hormone concentration or gender
treatment: 1) only male of a pair was treated, 2) only female was treated and 3) both male
and female were treated. While calling was not expected to occur in response to AVT
administration in boreal toads, as they do not naturally exhibit this behavior in the wild, it
was anticipated that they would at least exhibit other reproductive behaviors such as
amplexus (39). It should be noted that the boreal toad species may not have displayed
reproductive behavior because it does not naturally respond to AVT. While this is
unlikely, it is possible that the boreal toad does not rely on AVT alone for stimulating
reproductive behaviors. This species may have adapted a mechanism to circumvent the
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need for AVT and instead rely on other hormonal cues. The fact that the boreal toad does
not naturally display a mating call could also have affected AVT’s ability to stimulate
reproduction. This is one of the most notable behavioral differences between the B.
boreas boreas and B. fowleri species. Unlike the boreal toad, male Fowler’s toads
produce a very loud mating call. The administration of AVT was not only successful in
stimulating a call response in the Fowler’s toad, but also other behaviors such as
amplexus. It is possible that the effect of AVT requires stimulation of male calling
before other reproductive behaviors can ensue.
Since the boreal toad does not naturally elicit calling behavior, it is likely that this
species could rely more heavily on pheromonal cues during reproduction. This is similar
to other amphibian species, such as the rough skinned newt (8, 21). Research has found
that AVT is able to stimulate a multitude of reproductive behaviors in this species
including amplexus in males, phonotaxis, egg-laying and male-like behaviors in females
(8). This species uses pheromonal cues to detect potential mates and elicit breeding
behaviors. It is possible that AVT can elicit reproductive behavior in the boreal toad by
acting through pheromonal cues. Since this species did not display any reproductive
behaviors in this experiment, the toads may not have been stimulated to produce proper
pheromone signals. Another possibility is that some of the toad subjects may not have
been sexually aroused enough to respond to pheromone cues emitted from their
counterpart. Without the combined effect of producing and receiving these signals, the
boreal toads may not have been able to exhibit reproductive behaviors.
The Colorado Division of Wildlife has estimated that the life expectancy of the
toad can extend up to 12 years of age. The average age of the toads used in this
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experiment were approximately 12 years and were all raised in captivity. Therefore, it is
possible that these toads have surpassed their reproductive age. If the boreal toads used in
this experiment are too old to be reproductively active, they may not be producing
sufficient levels of endogenous sex steroids needed to elicit reproductive behaviors.
Thus, these animals may not have been the best model for our study as there are direct
correlations between AVT activity and the amount of sex steroids being produced. For
example, Moore et al. (2000) conducted an AVT study using the rough skinned newt that
observed a correlation between the numbers of AVT cell bodies and specific sex steroids
particular to each gender. In males, there were higher concentrations of AVT cell bodies
in the aPOA, BNST and AMYG while in females, receptors were associated with the
pardosalis and ventromedial hypothalamus. Thus, the sexual dimorphism of AVT
receptors is associated with sex-specific reproductive hormones. During the months of
egg-laying, the concentration of cell bodies expressing AVT in female rough skinned
newts increases and coincides with changes in sex steroids during this period. Studies
conducted by Boyd in 1994 and 1997 using the North American Bullfrog (Rana
catesbeiana) found a drop in vasotocin concentrations within particular brain regions
upon gonadectomy in both male and female subjects (10, 26). Administration of
dihydrotestosterone (DHT) to male subjects restored AVT concentrations in certain brain
regions while the administration of estrogen restored concentrations in others. These
ablation and hormone replacement studies provided direct evidence for a relationship
between AVT production and sex-specific steroids within the amphibian brain.
We suggest that the lack of behavioral response (e.g. amplexus) of boreal toads to
AVT is possibly because our animals were no longer producing sufficient levels of sex
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hormones needed for active reproduction. While steroid hormones, such as estrogen and
testosterone, have proven to be crucial in the display of reproductive behavior (7, 28),
their insufficient production may also be inhibiting AVT’s ability to elicit a behavioral
response.

The Effects of Arginine Vasotocin on Male Spermiation
Very few studies have been conducted that examined the effects of AVT on
amphibian male spermiation and none have been published in the male B. boreas boreas
and B. fowleri species. After completion of study 1, it was determined that administering
10.0 µg/g AVT attained the greatest behavioral response in the male B. fowleri. Hence,
we chose this AVT dose to administer to males of both species to see if AVT could also
achieve a spermiation response. Hypothetically, if a male were to exhibit amplexus, it
would be ideal for him to also produce sperm so that he may fertilize any eggs deposited
by the female. Unfortunately, urine could not be collected from the boreal toads at most
time points post administration. Urine was only able to be collected from one boreal toad
24 hours post administration. Unlike the boreal toad, all three Fowler’s toads did produce
urine samples for analysis, but only at a few time points (3, 5 and 25 hours post
administration) and in small quantities. Each of these samples was of 100µL or less and
did not contain any sperm.
It is possible that the toads of both species produced sperm, but may have ceased
before a urine sample could have been collected. Arginine vasotocin is the amphibian
analogue to the mammalian hormone, arginine vasopressin (AVP). AVP is often referred
to as the “anti-diuretic hormone” (ADH). This hormone acts on the kidney to cause an
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anti-diuretic effect and increase water retention (47). AVT has been observed to have the
same effect in many amphibian species (48-50). Administration of AVT may have
caused the toads to retain water and inhibit urine production. Administering a lower dose
of AVT may not have this inhibitory effect and future studies on the diuretic effect of
AVT in relation to hormone concentration should be evaluated.
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CHAPTER 6
CONCLUSION

Results from this investigation indicate that the best behavioral response was
attained in the B. fowleri toad when both male and female were administered 10.0 µg/g
AVT. Calling, amplexus, phonotaxis, male-like behavior and egg-deposition were all
attained from this treatment. To the best of the author’s knowledge, this is the first time
AVT has been reported to induce an amplexus response in an anuran species. The results
suggest that the stimulation of both males and females improved the display of
reproductive behaviors compared to either gender alone. B. fowleri males administered
10.0 µg/g AVT were not able to produce spermic urine. Interestingly, the administration
of AVT was not able to stimulate any reproductive behavior in the B. boreas boreas toad
nor were urine samples able to be collected for evaluation of spermiation.
Despite achieving some positive results with attaining reproductive behavior in
the B. fowleri species, caution is advised when applying this hormone in captive breeding
colonies. Some of the toads died shortly after the consecutive administration of high
AVT doses. Though it is not clear whether AVT was the cause of death, it is still
cautioned that this hormone be tested at low doses first to a limited sample of animals
before applying it on a larger scale.
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It is also noted that the cost of purchasing AVT is relatively expensive compared
to other commonly used hormones. Purchasing 1mg of AVT from Sigma-Aldrich (St.
Louis, MO) cost $116.00. In order to reconstitute the hormone for higher concentration
dosages, it was necessary to purchase vials containing 5mg AVT ($454.00 per vial). To
inject a single 40g toad with 10.0 µg/g AVT, it cost approximately $36.00. This can be
compared to human chorionic gonadotropin (hCG), in which a common dose of 400IU to
a 40g toad would approximately cost $5.00. Because of its high price and possible toxic
effect, it is suggested that other more commonly used reproductive hormones (such as
hCG, LHRH) be explored first when attempting to breed amphibians in captivity and
only be explored if the other hormones fail to elicit reproductive behaviors.
This investigation provided more insight into the mechanisms of reproduction employed
by two amphibian species, the boreal and Fowler’s toad. The importance of
simultaneously stimulating both male and female mates was also examined and found to
improve overall reproductive success in the Fowler’s toad. The knowledge gained from
this investigation can be applied to the development of hormone protocols in captive
breeding programs and assist in the conservation of endangered species.
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